Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 21, 2012; 18(47): 6908-6917
Published online Dec 21, 2012. doi: 10.3748/wjg.v18.i47.6908
Published online Dec 21, 2012. doi: 10.3748/wjg.v18.i47.6908
Indications | Ref. | |
Islet transplantation | Patients with type 1 diabetes with severe glycaemic lability, recurrent hypoglycemia, and a reduced hypoglycaemia awareness | Shapiro et al[84] Shapiro et al[51] Ryan et al[52] Matsumoto et al[54] Strom et al[57] Vantyghem et al[85] |
Hepatocyte transplantation | Inherited metabolic disorders: Familial hypercholesterolemia Urea cycle deficit α1 antitrypsin-deficiency Glycogen storage dz 1a Infantile refsum's dz Factor VII deficiency Crigler-Najar type 1 syndrome Progressive familial intrahepatic cholestasis | Grossman et al[86] Strom et al[87] Horlsen et al[88] Mitry et al[89] Fox et al[90] Muraca et al[91] Sokal et al[92] Dhawn et al[93] Hughes et al[62] Ambrosino et al[94] |
Chronic liver failure (Child A-C) | Sterling et al[61] Mito et al[60] Strom et al[95] | |
Acute liver failure (as bridge to transplant) | Strom et al[57] Sterling et al[61] Habibullah et al[96] Bilir et al[97] |
- Citation: Carbone M, Lerut J, Neuberger J. How regenerative medicine and tissue engineering may complement the available armamentarium in gastroenterology? World J Gastroenterol 2012; 18(47): 6908-6917
- URL: https://www.wjgnet.com/1007-9327/full/v18/i47/6908.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i47.6908